A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
Clinical trial NCT05574101 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05574101
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2026-10-06
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.